Gold nanoparticles as contrast agents in X-ray imaging and computed tomography

Nanomedicine

Volumn 10, Issue 2, 2015, Pages 321-341

  Cole, Lisa E ^a,b   Ross, Ryan D ^a   Tilley, Jennifer M ^a   Vargo Gogola, Tracy ^b,c   Roeder, Ryan K ^a,b  

^a University of Notre Dame   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

computed tomography; contrast agent; delivery; gold nanoparticles; surface functionalization; targeting; X ray imaging

Indexed keywords

CONTRAST MEDIUM; GOLD NANOPARTICLE; GOLD; METAL NANOPARTICLE;

COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG PENETRATION; DRUG RECEPTOR BINDING; ENDOTHELIUM; HUMAN; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; RADIOGRAPHY; REVIEW; STRUCTURE ACTIVITY RELATION; CHEMISTRY; DIAGNOSTIC USE; PROCEDURES;

CONTRAST MEDIA; DIAGNOSTIC IMAGING; GOLD; METAL NANOPARTICLES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84921496485     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.171     Document Type: Review

References (139)

1. Yu S-B, Watson AD. Metal-based X-ray contrast media. Chem. Rev. 99(9), 2353-2377 (1999).
2. Goldman LW. Principles of CT and CT technology. J. Nucl. Med. Technol. 35(3), 115-128 (2007).
3. de González AB, Mahesh M, Kim K-P et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch. Intern. Med. 169(22), 2071-2077 (2009).
4. Kalender WA. X-ray computed tomography. Phys. Med. Biol. 51(13), R29-R43 (2006).
5. Wang G, Yu H, De Man B. An outlook on X-ray CT research and development. Med. Phys. 35(3), 1051-1064 (2008).
6. Flohr TG, McCollough CH, Bruder H et al. First performance evaluation of a dual-source CT (DSCT) system. Eur. Radiol. 16(2), 256-268 (2006).
7. Roessl E, Proksa R. K-edge imaging in X-ray computed tomography using multi-bin photon counting detectors. Phys. Med. Biol. 52(15), 4679-4696 (2007).
8. Anderson NG, Butler AP. Clinical applications of spectral molecular imaging: potential and challenges. Contrast Media Mol. Imaging 9(1), 3-12 (2014).
9. Elliott A. Medical imaging. Nucl. Instrum. Meth. A 546(1-2), 1-13 (2005).
10. Kircher MF, Willmann JK. Molecular body imaging: MR imaging, CT, and US. Part I. Principles. Radiology 263(3), 633-643 (2012).
11. Goldman LW. Principles of CT: radiation dose and image quality. J. Nucl. Med. Technol. 35(4), 213-225 (2007).
12. Lee N, Choi SH, Hyeon T. Nano-sized CT contrast agents. Adv. Mater. 25(19), 2641-2660 (2013).
13. Osborne ED, Sutherland CG, School AJ, Rowntree LG. Roentgenography of urinary tract during excretion of sodium iodide. JAMA 250(20), 2848-2853 (1923).
14. Lusic H, Grinstaff MW. X-ray-computed tomography contrast agents. Chem. Rev. 113(3), 1641-1666 (2013).
15. Hallouard F, Anton N, Choquet P, Constantinesco A, Vandamme T. Iodinated blood pool contrast media for preclinical X-ray imaging applications-a review. Biomaterials 31(24), 6249-6268 (2010).
16. Rhee CM, Bhan I, Alexander EK, Brunelli SM. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch. Intern. Med. 172(2), 153-159 (2012).
17. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 49(18), N309-N315 (2004).
18. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br. J. Radiol. 79(939), 248-253 (2006).
19. Hubbell JH, Seltzer SM. Tables of X-ray mass attenuation coefficients and mass energy-absorption coefficients (version 1.4). National Institute of Standards and Technology, MD, USA (2004). www.nist.gov/pml/data/xraycoef/index.cfm
20. Sun I-C, Eun D-K, Na JH et al. Heparin-coated gold nanoparticles for liver-specific CT imaging. Chem. Eur. J. 15(48), 13341-13347 (2009).
21. Chanda N, Kattumuri V, Shukla R et al. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity. Proc. Natl Acad. Sci. USA 107(19), 8760-8765 (2010).
22. Cormode DP, Roessl E, Thran A et al. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology 256(3), 774-782 (2010).
23. Eck W, Nicholson AI, Zentgraf H, Semmler W, Bartling S. Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in X-ray computed tomography of live mice. Nano Lett. 10(7), 2318-2322 (2010).
24. Shilo M, Reuveni T, Motiei M, Popovtzer R. Nanoparticles as computed tomography contrast agents. Nanomedicine 7(2), 257-269 (2012).
25. Jakhmola A, Anton N, Vandamme TF. Inorganic nanoparticles based contrast agents for X-ray computed tomography. Adv. Healthc. Mater. 1(4), 413-431 (2012).
26. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56(11), 1649-1659 (2004).
27. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54(5), 631-651 (2002).
28. Tomalia DA. In quest of a systematic framework for unifying and defining nanoscience. J. Nanopart. Res. 11(6), 1251-1310 (2009).
29. Kannan RM, Nance E, Kannan S, Tomalia DA. Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications. J. Intern. Med. 276(6), 579-617 (2014).
30. Sabel M, Aichinger H. Recent developments in breast imaging. Phys. Med. Biol. 41(3), 315-368 (1996).
31. Huda W, Gkanatsios NA. Radiation dosimetry for extremity radiographs. Health Phys. 75(5), 492-499 (1998).
32. Ross RD, Cole LE, Tilley JMR, Roeder RK. Effects of functionalized gold nanoparticle size on X-ray attenuation and substrate binding affinity. Chem. Mater. 26(2), 1187-1194 (2014).
33. Rigley S, Rigon L, Ataelmannan K et al. Absorption edge subtraction imaging for volumetric measurement in an animal model of malignant brain tumor. Nucl. Instrum. Meth. A 548(1-2), 88-93 (2005).
34. Cai Q-Y, Kim SH, Choi KS et al. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice. Invest. Radiol. 42(12), 797-806 (2007).
35. Kim D, Park S, Lee JH, Jeong YY, Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J. Am. Chem. Soc. 129(24), 7661-7665 (2007).
36. Xu C, Tung GA, Sun S. Size and concentration effect of gold nanoparticles on X-ray attenuation as measured on computed tomography. Chem. Mater. 20(13), 4167-4169 (2008).
37. Guo R, Wang H, Peng C et al. X-ray attenuation property of dendrimer-entrapped gold nanoparticles. J. Phys. Chem. C 114(1), 50-56 (2010).
38. Kojima C, Umeda Y, Ogawa M, Harada A, Magata Y, Kono K. X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer. Nanotechnology 21(24), 245104 (2010).
39. Jackson PA, Rahman WNWA, Wong CJ, Ackerly T, Geso M. Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents. Eur. J. Radiol. 75(1), 104-109 (2010).
40. Wang H, Zheng L, Guo R et al. Dendrimer-entrapped gold nanoparticles as potential CT contrast agents for blood pool imaging. Nanoscale Res. Lett. 7, 190 (2012).
41. Galper MW, Saung MT, Fuster V et al. Effect of computed tomography scanning parameters on gold nanoparticle and iodine contrast. Invest. Radiol. 47(8), 475-481 (2012).
42. Peng C, Wang H, Guo R et al. Acetylation of dendrimer-entrapped gold nanoparticles: synthesis, stability, and X-ray attenuation properties. J. Appl. Polym. Sci. 119(3), 1673-1682 (2011).
43. Berger MJ, Hubbell JH, Seltzer SM et al. XCOM: photon cross section database (version 1.5). National Institute of Standards and Technology, MD, USA (2010). www.nist.gov/pml/data/xcom/index.cfm
44. Hubbell JH, Gimm HA, Overbo IJ. Pair, triplet, and total atomic cross sections (and mass attenuation coefficients) for 1 MeV-100 GeV photons in elements Z=1 to 100. J. Phys. Chem. Ref. Data 9, 1023-1147 (1980).
45. Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS. Molecular imaging in drug development. Nat. Rev. Drug Discov. 7(7), 591-607 (2008).
46. Huang P, Le Bao, Zhang C et al. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials 32(36), 9796-9809 (2011).
47. Hainfeld JF, O'Connor MJ, Dilmanian FA, Slatkin DN, Adams DJ, Smilowitz HM. Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. Br. J. Radiol. 84(1002), 526-533 (2011).
48. Sun I-C, Na JH, Jeong SY et al. Biocompatible glycol chitosan-coated gold nanoparticles for tumor-targeting CT imaging. Pharm. Res. 31(6), 1418-1425 (2014).
49. Krause W. Delivery of diagnostic agents in computed tomography. Adv. Drug Deliv. Rev. 37(1-3), 159-173 (1999).
50. Kouris K, Spyrou NM, Jackson DF. Minimum detectable quantities of elements and compounds in a biological matrix. Nucl. Instrum. Meth. Phys. Res. 187(2-3), 539-545 (1981).
51. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6(4), 662-668 (2006).
52. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 422, 37-44 (2003).
53. Albanese A, Chan WCW. Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano 5(7), 5478-5489 (2011).
54. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem. Rev. 111(9), 5610-5637 (2011).
55. Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 40(3), 1647-1671 (2011).
56. Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J. Nanopart. Res. 12(7), 2313-2333 (2010).
57. Peng C, Zheng L, Chen Q et al. PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials 33(4), 1107-1119 (2012).
58. Alric C, Taleb J, Le Duc G et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J. Am. Chem. Soc. 130(18), 5908-5915 (2008).
59. Boote E, Fent G, Kattumuri V et al. Gold nanoparticle contrast in a phantom and juvenile swine: models for molecular imaging of human organs using X-ray computed tomography. Acad. Radiol. 17(4), 410-417 (2010).
60. Cole LE, Vargo-Gogola T, Roeder RK. Contrast-enhanced X-ray detection of breast microcalcifications in a murine model using targeted gold nanoparticles. ACS Nano 8(7), 7486-7496 (2014).
61. Peng C, Qin J, Zhou B et al. Targeted tumor CT imaging using folic acid-modified PEGylated dendrimer-entrapped gold nanoparticles. Polym. Chem. 4(16), 4412-4424 (2013).
62. Sinha R, Kim GJ, Nie S, Shin DM. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol. Cancer Ther. 5(8), 1909-1917 (2006).
63. Popovtzer R, Agrawal A, Kotov NA et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett. 8(12), 4593-4596 (2008).
64. Eck W, Craig G, Sigdel A et al. PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. ACS Nano 2(11), 2263-2272 (2008).
65. Chanda N, Shukla R, Katti KV, Kannan R. Gastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imaging. Nano Lett. 9(5), 1798-1805 (2009).
66. Aydogan B, Li J, Rajh T et al. AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging. Mol. Imaging Biol. 12(5), 463-467 (2010).
67. Li J, Chaudhary A, Chmura SJ et al. A novel functional CT contrast agent for molecular imaging of cancer. Phys. Med. Biol. 55(15), 4389-4397 (2010).
68. Kim D, Jeong YY, Jon S. A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 4(7), 3689-3696 (2010).
69. Reuveni T, Motiei M, Romman Z, Popovtzer A, Popovtzer R. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int. J. Nanomed. 6, 2859-2864 (2011).
70. Chattopadhyay N, Cai Z, Kwon YL, Lechtman E, Pignol J-P, Reilly RM. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to x-radiation. Breast Cancer Res. Treat. 137(1), 81-91 (2013).
71. Wang H, Zheng L, Peng C, Shen M, Shi X, Zhang G. Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma. Biomaterials 34(2), 470-480 (2013).
72. Yao L, Daniels J, Moshnikova A et al. pHLIP peptide targets nanogold particles to tumors. Proc. Natl Acad. Sci. USA 110(2), 465-470 (2013).
73. Ross RD, Roeder RK. Binding affinity of surface functionalized gold nanoparticles to hydroxyapatite. J. Biomed. Mater. Res. 99A(1), 58-66 (2011).
74. Lasagna-Reeves C, Gonzalez-Romero D, Barria MA et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem. Biophys. Res. Commun. 393(4), 649-655 (2010).
75. Pernodet N, Fang X, Sun Y et al. Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2(6), 766-773 (2006).
76. Mironava T, Hadjiargyrou M, Simon M, Jurukovski V, Rafailovich MH. Gold nanoparticles cellular toxicity and recovery: effect of size, concentration and exposure time. Nanotoxicology 4(1), 120-137 (2010).
77. Zhang X-D, Wu H-Y, Wu D et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int. J. Nanomed. 5, 771-781 (2010).
78. Cho W-S, Cho M, Jeong J et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol. Appl. Pharm. 236(1), 16-24 (2009).
79. Cho W-S, Kim S, Han BS, Son WC, Jeong J. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. Toxicol. Lett. 191(1), 96-102 (2009).
80. Chen Y-S, Hung Y-C, Liau I, Huang GS. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res. Lett. 4(8), 858-864 (2009).
81. Daniel M-C, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104(1), 293-346 (2004).
82. Link S, El-Sayed MA. Size and temperature dependence of the plasmon absorption of colloidal gold nanoparticles. J. Phys. Chem. B 103(21), 4212-4217 (1999).
83. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J. Phys. Chem. B 110(14), 7238-7248 (2006).
84. Jackson P, Periasamy S, Bansal V, Geso M. Evaluation of the effects of gold nanoparticle shape and size on contrast enhancement in radiological imaging. Australas. Phys. Eng. Sci. Med. 34(2), 243-249 (2011).
85. Luo T, Huang P, Gao G et al. Mesoporous silica-coated gold nanorods with embedded indocyanine green for dual mode X-ray CT and NIR fluorescence imaging. Opt. Express 19(18), 17030-17039 (2011).
86. Lammers T, Aime S, Hennink WE, Storm G, Kiessling F. Theranostic nanomedicine. Acc. Chem. Res. 44(10), 1029-1038 (2011).
87. Liu Y, Shipton MK, Ryan J, Kaufman ED, Franzen S, Feldheim DL. Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers. Anal. Chem. 79(6), 2221-2229 (2007).
88. Zhang G, Yang Z, Lu W et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 30(10), 1928-1936 (2009).
89. Ghosh SK, Pal T. Interparticle coupling effect on the surface plasmon resonance of gold nanoparticles: from theory to applications. Chem. Rev. 107(11), 4797-4862 (2007).
90. Zhou J, Ralston J, Sedev R, Beattie DA. Functionalized gold nanoparticles: synthesis, structure and colloid stability. J. Colloid Interf. Sci. 331(2), 251-262 (2009).
91. Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 14(1), 1-16 (2012).
92. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf. B Biointerfaces 66(2), 274-280 (2008).
93. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJAM, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29(12), 1912-1919 (2008).
94. Shilo M, Motiei M, Hana P, Popovtzer R. Transport of nanoparticles through the blood-brain barrier for imaging and therapeutic applications. Nanoscale 6(4), 2146-2152 (2014).
95. Olivier J-C. Drug transport to brain with targeted nanoparticles. NeuroRx 2(1), 108-119 (2005).
96. Niidome T, Yamagata M, Okamoto Y et al. PEG-modified gold nanorods with a stealth character for in vivo applications. J. Control. Release 114(3), 343-347 (2006).
97. Chithrani BD, Chan WCW. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 7(6), 1542-1550 (2007).
98. Gao H, Shi W, Freud LB. Mechanics of receptor-mediated endocytosis. Proc. Natl Acad. Sci. USA 102(27), 9469-9474 (2005).
99. Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WCW. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 9(5), 1909-1915 (2009).
100. Pan Y, Neuss S, Leifert A et al. Size-dependent cytotoxicity of gold nanoparticles. Small 3(11), 1941-1949 (2007).
101. Pan Y, Leifert A, Ruau D et al. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 5(18), 2067-2076 (2009).
102. Tsoli M, Kuhn H, Brandau W, Esche H, Schmid G. Cellular uptake and toxicity of Au55 clusters. Small 1(8-9), 841-844 (2005).
103. Prasad BLV, Stoeva SI, Sorensen CM, Klabunde KJ. Digestive-ripening agents for gold nanoparticles: alternatives to thiols. Chem. Mater. 15(4), 935-942 (2003).
104. Giersig M, Mulvaney P. Preparation of ordered colloid monolayers by electrophoretic deposition. Langmuir 9(12), 3408-3413 (1993).
105. Brust M, Walker M, Bethell D, Schiffrin DJ, Whyman R. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system. J. Chem. Soc. Chem. Commun. 7, 801-802 (1994).
106. Brust M, Fink J, Bethell D, Schiffrin DJ, Kiely C. Synthesis and reactions of functionalised gold nanoparticles. J. Chem. Soc. Chem. Comm. 16, 1655-1656 (1995).
107. Leff DV, Brandt L, Heath JR. Synthesis and characterization of hydrophobic, organically-soluble gold nanocrystals functionalized with primary amines. Langmuir 12(20), 4723-4730 (1996).
108. Aslam M, Fu L, Su M, Vijayamohanan K, Dravid VP. Novel one-step synthesis of amine-stabilized aqueous colloidal gold nanoparticles. J. Mater. Chem. 14(12), 17951797 (2004).
109. Brown LO, Hutchison JE. Formation and electron diffraction studies of ordered 2-D and 3-D superlattices of amine-stabilized gold nanocrystals. J. Phys. Chem. B 105(37), 8911-8916 (2001).
110. Porter LA, Ji D, Westcott SL et al. Gold and silver nanoparticles functionalized by the adsorption of dialkyl disulfides. Langmuir 14(26), 7378-7386 (1998).
111. Yonezawa T, Yasui K, Kimizuka N. Controlled formation of smaller gold nanoparticles by the use of four-chained disulfide stabilizer. Langmuir 17(2), 271-273 (2001).
112. Yao H, Momozawa O, Hamatani T, Kimura K. Stepwise size-selective extraction of carboxylate-modified gold nanoparticles from an aqueous suspension into toluene with tetraoctylammonium cations. Chem. Mater. 13(12), 4692-4697 (2001).
113. Weare WW, Reed SM, Warner MG, Hutchison JE Improved synthesis of small (dcore ≈ 1.5 nm) phosphine-stabilized gold nanoparticles. J. Am. Chem. Soc. 122(51), 12890-12891 (2000).
114. Schmid G. Large clusters and colloids. Metals in the embryonic state. Chem. Rev. 92(8), 1709-1727 (1992).
115. Selvakannan P, Mandal S, Phadtare S, Pasricha R, Sastry M. Capping of gold nanoparticles by the amino acid lysine renders them water-dispersible. Langmuir 19(8), 3545-3549 (2003).
116. Love JC, Estroff LA, Kriebel JK, Nuzzo RG, Whitesides GM. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem. Rev. 105(4), 1103-1170 (2005).
117. Yang M, Yau HC, Chan HL. Adsorption kinetics and ligand-binding properties of thiol-modified double-stranded DNA on a gold surface. Langmuir 14(21), 6121-6129 (1998).
118. Esumi K, Suzuki A, Aihara N, Usui K, Torigoe K. Preparation of gold colloids with UV irradiation using dendrimers as stabilizer. Langmuir 14(12), 3157-3159 (1998).
119. Garcia ME, Baker LA, Crooks RM. Preparation and characterization of dendrimer-gold colloid nanocomposites. Anal. Chem. 71(1), 256-258 (1999).
120. Esumi K, Suzuki A, Yamahira A, Torigoe K. Role of poly(amidoamine) dendrimers for preparing nanoparticles of gold, platinum, and silver. Langmuir 16(6), 2604-2608 (2000).
121. Shi X, Wang S, Sun H, Baker JR. Improved biocompatibility of surface functionalized dendrimer-entrapped gold nanoparticles. Soft Matter 3(1), 71-74 (2007).
122. Shi X, Wang S, Meshinchi S et al. Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 3(7), 1245-1252 (2007).
123. Liu H, Xu Y, Wen S et al. Targeted tumor computed tomography imaging using low-generation dendrimer-stabilized gold nanoparticles. Chem. Eur. J. 19(20), 6409-6416 (2013).
124. Wang H, Zheng L, Peng C et al. Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles. Biomaterials 32(11), 2979-2988 (2011).
125. Chen Q, Li K, Wen S et al. Targeted CT/MR dual model imaging of tumors using multifunctional dendrimer-entrapped gold nanoparticles. Biomaterials 34(21), 5200-5209 (2013).
126. Tomalia DA. Dendrons/dendrimers: quantized, nano-element like building blocks for soft-soft and soft-hard nano-compound synthesis. Soft Matter 6(3), 456-747 (2010).
127. Sperling RA, Rivera Gil P, Zhang F, Zanella M, Parak WJ. Biological applications of gold nanoparticles. Chem. Soc. Rev. 37(9), 1896-1908 (2008).
128. Kattumuri V, Katti K, Bhaskaran S et al. Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies. Small 3(2), 333-341 (2007).
129. Ross RD, Cole LE, Roeder RK. Relative binding affinity of carboxylate-, phosphonate-, and bisphosphonate-functionalized gold nanoparticles targeted to damaged bone tissue. J. Nanopart. Res. 14(10), 1175 (2012).
130. Cole LE, Vargo-Gogola T, Roeder RK. Bisphosphonate-functionalized gold nanoparticles for contrast-enhanced X-ray detection of breast microcalcifications. Biomaterials 35(7), 2312-2321 (2014).
131. Zhang Z, Ross RD, Roeder RK. Preparation of functionalized gold nanoparticles as a targeted X-ray contrast agent for damaged bone tissue. Nanoscale 2(4), 582-586 (2010).
132. Allijn IE, Leong W, Tang J et al. Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level. ACS Nano 7(11), 9761-9770 (2013).
133. Choi CHJ, Alabi CA, Webster P, Davis ME. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc. Natl Acad. Sci. USA 107(3), 1235-1240 (2010).
134. Zhou J, Beattie DA, Ralston J, Sedev R. Colloid stability of thymine-functionalized gold nanoparticles. Langmuir 23(24), 12096-12103 (2007).
135. Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev. 55(3), 403-419 (2003).
136. Hayashi K, Nakamura M, Miki H et al. Gold nanoparticle cluster-plasmon-enhanced fluorescent silica core-shell nanoparticles for X-ray computed tomography-fluorescence dual-mode imaging of tumors. Chem. Commun. 49(46), 5334 (2013).
137. Kah JCY, Wong KY, Neoh KG et al. Critical parameters in the PEGylation of gold nanoshells for biomedical applications: an in vitro macrophage study. J. Drug Target. 17(3), 181-193 (2009).
138. Cho W-S, Cho M, Jeong J et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol. Appl. Pharm. 245(1), 116-123 (2010).
139. Chattopadhyay N, Fonge H, Cai Z et al. Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo. Mol. Pharm. 9(8), 2168-2179 (2012).